Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Becton, Dickinson And Co.
Nieuws
Becton, Dickinson And Co.
BDX
NYS
: BDX
| ISIN: US0758871091
23/12/2025
195,67 USD
(-0,54%)
(-0,54%)
23/12/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
18 december 2025 ·
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry
· Persbericht
15 december 2025 ·
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec
· Persbericht
4 december 2025 ·
BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories
· Persbericht
3 december 2025 ·
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
· Persbericht
24 november 2025 ·
BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety
· Persbericht
17 november 2025 ·
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors
· Persbericht
17 november 2025 ·
BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification
· Persbericht
13 november 2025 ·
Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH
· Persbericht
12 november 2025 ·
BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go
· Persbericht
6 november 2025 ·
BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
· Persbericht
6 november 2025 ·
BD Board Increases Dividend for 54th Consecutive Year
· Persbericht
4 november 2025 ·
BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease
· Persbericht
3 november 2025 ·
BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System
· Persbericht
22 oktober 2025 ·
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States
· Persbericht
20 oktober 2025 ·
BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings
· Persbericht
16 oktober 2025 ·
BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region
· Persbericht
15 oktober 2025 ·
BD Announces CFO Transition Plan
· Persbericht
9 oktober 2025 ·
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025
· Persbericht
9 oktober 2025 ·
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease
· Persbericht
8 oktober 2025 ·
BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe